In the midst of shifting political headwinds and a tight funding market, many life sciences companies are considering their M&A exit.

Opinion: Sullivan & Cromwell attorneys Frank Aquila and Catherine Yuh say firms that don't take advantage of AI to identify M&A targets will be left behind by competitors.